Dyslipidemia clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
Sorry, in progress, not accepting new patients
Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants with established cardiovascular disease (CVD).
Irvine 5359777, California 5332921 and other locations

Last updated: August 4, 2025